Cargando…
Botulinum Toxin Type A Therapy in Migraine: Preclinical and Clinical Trials
BACKGROUND: Botulinum toxin type A (BTX-A) has been reported to be effective for the therapy for migraine. The purpose of this study was to investigate the effect of BTX-A on the immunoreactive levels of calcitonin gene-related peptide (CGRP) and substance P (SP) in the jugular plasma and medulla ob...
Autores principales: | Shao, Yu-Feng, Zhang, Yi, Zhao, Peng, Yan, Wen-Jun, Kong, Xiang-Pan, Fan, Lin-Lan, Hou, Yi-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950781/ https://www.ncbi.nlm.nih.gov/pubmed/24693369 http://dx.doi.org/10.5812/ircmj.7704 |
Ejemplares similares
-
The Inhibitory Effect of Botulinum Toxin Type A on Rat Pyloric Smooth Muscle Contractile Response to Substance P In Vitro
por: Shao, Yu-Feng, et al.
Publicado: (2015) -
Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
por: Robertson, Carrie E, et al.
Publicado: (2012) -
EHMTI-0037. Botulinum A toxin for treatment of chronic migraine
por: Grazzi, L, et al.
Publicado: (2014) -
There is Value in Anecdotal Reports of Relief from Migraine with Botulinum Toxin
por: Winett, Bill
Publicado: (2009) -
Botulinum toxin type A in
prophylactic treatment of migraine headaches: a preliminary
study
por: Barrientos, Nelson, et al.
Publicado: (2003)